Baptist Cancer Services offers patients participation in clinical trials. Following are the clinical trials currently available as of September 2013. For more information, contact our Baptist Cancer Services Navigator, Tonya Ball, at 601-974-6238.
Puma Biotechnology - Neratinib plus Xeloda versus Tykerb plus Xeloda in patients with HER 2 positive metastatic breast cancer who have received two or more regimens for metastatic disease
Sanofi - Observational trial for metastatic colon cancer patients receiving Zaltrap in combination with FOLFIRI
Randomized Study of Idelalisib with Rituxan and Treanda for previously treated indolent non-hodgkins lymphoma
Celgene– phase 3 randomized, double-blind study to compare efficacy and safety of Oral Azacitidine versus placebo plus best supportive care in subjects with RBC transfusion dependent anemia and thrombocytopenia due to IPSS lower risk MDS
Sanofi –Open label study comparing Cabazitaxel at 20 mg/m2 and 25 mg/m2 for treatment of metastatic HRPC previously treated with taxotere;
Cabazitaxel is provided by study
What can we help you find?